Search research articles
Contact Us
Filters
Showing results (11-20 of 90) with videos related to
Page
of 9
Sort By:
Chemmedchem
|
October 13, 2011
The tubulin colchicine domain: a molecular modeling perspective
Alberto Massarotti, Antonio Coluccia, Romano Silvestri, et al.
Proteins
|
April 19, 2022
Exploring CCRL2 chemerin binding using accelerated molecular dynamics
Marianna Bufano, Mattia Laffranchi, Silvano Sozzani, et al.
Future Medicinal Chemistry
|
November 23, 2013
Arylsulfone-based HIV-1 non-nucleoside reverse transcriptase inhibitors
Valeria Famiglini, Antonio Coluccia, Andrea Brancale, et al.
Communications Chemistry
|
January 27, 2023
Enzymatic kinetic resolution of desmethylphosphinothricin indicates that phosphinic group is a bioisostere of carboxyl group
Daniela De Biase, Francesca Cappadocio, Eugenia Pennacchietti, et al.
ACS Infectious Diseases
|
December 23, 2024
Non-Polio Enterovirus Inhibitors: Scaffolds, Targets, and Potency─What's New?
Hugo Fernando Georges Roux, Franck Touret, Pascal Rathelot, et al.
Virology Journal
|
July 15, 2015
In vitro characterisation of a pleconaril/pirodavir-like compound with potent activity against rhinoviruses
Céline Lacroix, Samuela Laconi, Fabrizio Angius, et al.
Journal of Computer-Aided Molecular Design
|
July 24, 2020
Modeling Epac1 interactions with the allosteric inhibitor AM-001 by co-solvent molecular dynamics
Marianna Bufano, Marion Laudette, Jean-Paul Blondeau, et al.
Journal of Medicinal Chemistry
|
January 7, 2005
Docking and 3-D QSAR studies on indolyl aryl sulfones. Binding mode exploration at the HIV-1 reverse transcriptase non-nucleoside binding site and design of highly active N-(2-hydroxyethyl)carboxamide and N-(2-hydroxyethyl)carbohydrazide derivatives
Rino Ragno, Marino Artico, Gabriella De Martino, et al.
European Journal of Medicinal Chemistry
|
April 7, 2016
VP1 crystal structure-guided exploration and optimization of 4,5-dimethoxybenzene-based inhibitors of rhinovirus 14 infection
Laurène Da Costa, Manon Roche, Els Scheers, et al.
Bioorganic & Medicinal Chemistry Letters
|
May 6, 2009
Discovery of a novel HCV helicase inhibitor by a de novo drug design approach
Sahar Kandil, Sonia Biondaro, Dimitrios Vlachakis, et al.
Page
of 9
Search research articles
Search
Showing results (11-20 of 90) with videos related to
Sort By:
Page
of 9
Chemmedchem
|
October 13, 2011
The tubulin colchicine domain: a molecular modeling perspective
Alberto Massarotti, Antonio Coluccia, Romano Silvestri, et al.
Proteins
|
April 19, 2022
Exploring CCRL2 chemerin binding using accelerated molecular dynamics
Marianna Bufano, Mattia Laffranchi, Silvano Sozzani, et al.
Future Medicinal Chemistry
|
November 23, 2013
Arylsulfone-based HIV-1 non-nucleoside reverse transcriptase inhibitors
Valeria Famiglini, Antonio Coluccia, Andrea Brancale, et al.
Communications Chemistry
|
January 27, 2023
Enzymatic kinetic resolution of desmethylphosphinothricin indicates that phosphinic group is a bioisostere of carboxyl group
Daniela De Biase, Francesca Cappadocio, Eugenia Pennacchietti, et al.
ACS Infectious Diseases
|
December 23, 2024
Non-Polio Enterovirus Inhibitors: Scaffolds, Targets, and Potency─What's New?
Hugo Fernando Georges Roux, Franck Touret, Pascal Rathelot, et al.
Virology Journal
|
July 15, 2015
In vitro characterisation of a pleconaril/pirodavir-like compound with potent activity against rhinoviruses
Céline Lacroix, Samuela Laconi, Fabrizio Angius, et al.
Journal of Computer-Aided Molecular Design
|
July 24, 2020
Modeling Epac1 interactions with the allosteric inhibitor AM-001 by co-solvent molecular dynamics
Marianna Bufano, Marion Laudette, Jean-Paul Blondeau, et al.
Journal of Medicinal Chemistry
|
January 7, 2005
Docking and 3-D QSAR studies on indolyl aryl sulfones. Binding mode exploration at the HIV-1 reverse transcriptase non-nucleoside binding site and design of highly active N-(2-hydroxyethyl)carboxamide and N-(2-hydroxyethyl)carbohydrazide derivatives
Rino Ragno, Marino Artico, Gabriella De Martino, et al.
European Journal of Medicinal Chemistry
|
April 7, 2016
VP1 crystal structure-guided exploration and optimization of 4,5-dimethoxybenzene-based inhibitors of rhinovirus 14 infection
Laurène Da Costa, Manon Roche, Els Scheers, et al.
Bioorganic & Medicinal Chemistry Letters
|
May 6, 2009
Discovery of a novel HCV helicase inhibitor by a de novo drug design approach
Sahar Kandil, Sonia Biondaro, Dimitrios Vlachakis, et al.
Page
of 9